EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
13.47
-0.13 (-0.96%)
At close: Apr 28, 2026, 4:00 PM EDT
13.45
-0.02 (-0.15%)
After-hours: Apr 28, 2026, 6:14 PM EDT

EyePoint Revenue

In the year 2025, EyePoint had annual revenue of $31.37M, down -27.50%. EyePoint had revenue of $620.00K in the quarter ending December 31, 2025, a decrease of -94.65%.

Revenue (ttm)
$31.37M
Revenue Growth
-27.50%
P/S Ratio
35.82
Revenue / Employee
$146,593
Employees
214
Market Cap
1.12B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202531.37M-11.90M-27.50%
Dec 31, 202443.27M-2.75M-5.97%
Dec 31, 202346.02M4.61M11.14%
Dec 31, 202241.40M4.47M12.09%
Dec 31, 202136.94M2.50M7.27%
Dec 31, 202034.44M14.07M69.10%
Dec 31, 201920.37M15.79M345.53%
Dec 31, 20184.57M1.61M54.37%
Sep 30, 20182.96M--
Jun 30, 20182.96M--
Dec 31, 20172.96M-4.58M-60.72%
Jun 30, 20177.54M--
Dec 31, 20167.54M5.92M365.37%
Jun 30, 20161.62M--
Dec 31, 20151.62M-24.95M-93.90%
Jun 30, 201526.57M23.09M664.90%
Jun 30, 20143.47M1.33M62.06%
Jun 30, 20132.14M-1.38M-39.22%
Jun 30, 20123.53M-1.44M-28.98%
Jun 30, 20114.97M-18.09M-78.46%
Jun 30, 201023.05M10.89M89.55%
Jun 30, 200912.16M8.69M249.88%
Jun 30, 20083.48M1.69M94.73%
Jun 30, 20071.79M749.00K72.30%
Jun 30, 20061.04M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pharming Group376.13M
UroGen Pharma109.79M
Septerna45.95M
uniQure16.10M
Zenas BioPharma10.00M
Inventiva7.94M
Aktis Oncology6.50M
DBV Technologies5.64M
Revenue Rankings